Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.

Literature DB >> 5648476

Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.

F M Davenport, A V Hennessy, F B Askin.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1968 PMID： 5648476

Source DB: PubMed Journal: J Immunol ISSN： 0022-1767 Impact factor: 5.422

Keyword Cloud
Cited

× No keyword cloud information.

18 in total

Review 1. The development and use of vaccine adjuvants.

Authors: Robert Edelman
Journal: Mol Biotechnol Date: 2002-06 Impact factor: 2.695

Review 2. Immunity to influenza: the challenges of protecting an aging population.

Authors: Jacqueline M Katz; Julie Plowden; Mary Renshaw-Hoelscher; Xiuhua Lu; Terrence M Tumpey; Suryaprakash Sambhara
Journal: Immunol Res Date: 2004 Impact factor: 2.829

3. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.

Authors: C W Potter; R Jennings; C McLaren; D Edey; C H Stuart-Harris; M Brady
Journal: J Hyg (Lond) Date: 1975-12

Review 4. Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors: Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal: Hum Vaccin Immunother Date: 2013-12-03 Impact factor: 3.452

5. Advances in vaccine technology and their impact on managed care.

Authors: Jonathan A McCullers; Jeffrey D Dunn
Journal: P T Date: 2008-01

6. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

Authors: Wendy A Keitel; James D Campbell; John J Treanor; Emmanuel B Walter; Shital M Patel; Fenhua He; Diana L Noah; Heather Hill
Journal: J Infect Dis Date: 2008-11-01 Impact factor: 5.226

Lack of adjuvant effect of A1PO4 on purified influenza virus hemagglutinins in man.

Review 1. The development and use of vaccine adjuvants.

Review 2. Immunity to influenza: the challenges of protecting an aging population.

3. A new surface-antigen-adsorbed influenza virus vaccine. II. Studies in a volunteer group.

Review 4. Recent progress in adjuvant discovery for peptide-based subunit vaccines.

5. Advances in vaccine technology and their impact on managed care.

6. Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

7. Calcium phosphate nanoparticle adjuvant.

8. A novel laser vaccine adjuvant increases the motility of antigen presenting cells.

9. Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

10. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine.